Guidelines for experimental models of myocardial ischemia and infarction
Myocardial infarction is a prevalent major cardiovascular event that arises from myocardial
ischemia with or without reperfusion, and basic and translational research is needed to …
ischemia with or without reperfusion, and basic and translational research is needed to …
Stem cell therapy in heart diseases–cell types, mechanisms and improvement strategies
P Müller, H Lemcke, R David - Cellular Physiology and Biochemistry, 2018 - karger.com
A large number of clinical trials have shown stem cell therapy to be a promising therapeutic
approach for the treatment of cardiovascular diseases. Since the first transplantation into …
approach for the treatment of cardiovascular diseases. Since the first transplantation into …
Guidelines for in vivo mouse models of myocardial infarction
Despite significant improvements in reperfusion strategies, acute coronary syndromes all too
often culminate in a myocardial infarction (MI). The consequent MI can, in turn, lead to …
often culminate in a myocardial infarction (MI). The consequent MI can, in turn, lead to …
Bcl-2 engineered MSCs inhibited apoptosis and improved heart function
Engraftment of mesenchymal stem cells (MSCs) derived from adult bone marrow has been
proposed as a potential therapeutic approach for postinfarction left ventricular dysfunction …
proposed as a potential therapeutic approach for postinfarction left ventricular dysfunction …
[HTML][HTML] Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies
OBJECTIVES: Cell therapy may offer novel therapeutic options for chronic ischemic heart
disease. In a clinical trial, we first assessed the feasibility and safety of intramyocardial …
disease. In a clinical trial, we first assessed the feasibility and safety of intramyocardial …
Uterine stem cells: from basic research to advanced cell therapies
X Santamaria, A Mas, I Cervelló… - Human Reproduction …, 2018 - academic.oup.com
BACKGROUND Stem cell research in the endometrium and myometrium from animal
models and humans has led to the identification of endometrial/myometrial stem cells and …
models and humans has led to the identification of endometrial/myometrial stem cells and …
Mesenchymal stromal cells from umbilical cord blood
K Bieback, H Kluter - Current stem cell research & therapy, 2007 - ingentaconnect.com
Mesenchymal Stromal Cells (MSC) are key candidates for cellular therapies. Although most
therapeutic applications have focused on adult bone marrow derived MSC, increasing …
therapeutic applications have focused on adult bone marrow derived MSC, increasing …
Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration
R Gaebel, D Furlani, H Sorg, B Polchow, J Frank… - Plos one, 2011 - journals.plos.org
The possible different therapeutic efficacy of human mesenchymal stem cells (hMSC)
derived from umbilical cord blood (CB), adipose tissue (AT) or bone marrow (BM) for the …
derived from umbilical cord blood (CB), adipose tissue (AT) or bone marrow (BM) for the …
Embryonic stem cell–derived endothelial cells engraft into the ischemic hindlimb and restore perfusion
Objective—We examined the effect of delivery modality on the survival, localization, and
functional effects of exogenously administered embryonic stem cells (ESCs) or endothelial …
functional effects of exogenously administered embryonic stem cells (ESCs) or endothelial …
Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial
Aims Intra-myocardial transplantation of CD133+ bone marrow stem cells (BMC) yielded
promising results in clinical pilot trials. We now performed the double-blinded, randomized …
promising results in clinical pilot trials. We now performed the double-blinded, randomized …